{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:01:42Z","timestamp":1783699302509,"version":"3.55.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Wiskott\u2013Aldrich syndrome (WAS) is a condition characterized by a low platelet count, eczema, and a weakened immune system. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment option. Haploidentical HSCT with posttransplant cyclophosphamide (PTCy) is an emerging approach for children with noncancerous conditions. This case describes a WAS patient who was early diagnosed and successfully treated with haploidentical HSCT. A 3-month-old boy presented with widespread eczema, a low platelet count, and severe infections in infancy. The diagnosis of WAS was quickly confirmed by genetic test. He received immunoglobulin replacement therapy and antimicrobial prophylaxis and underwent HSCT at 4 years 3 months of age. After failed unrelated cord blood HSCT, second rescue haploidentical HSCT had been performed using the patient\u2019s mother as the donor, with stem cells collected from peripheral blood. The conditioning regimen included anti-thymocyte globulin, melphalan, and fludarabine. The stem cell dose was 2.63 \u00d7 106 CD34+ cells\/kg. GVHD prevention included PTCy, mycophenolat mofetil, and tacrolimus. The patient had no significant complications after the transplant. Neutrophil and platelet engraftment occurred promptly. At 32 months post-HSCT, the patient had complete hematological and immune reconstitution, with full donor chimerism and no GVHD. In conclusion, the PTCy approach to haploidentical HSCT was a safe and effective treatment for this WAS patient.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1495666","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T06:31:56Z","timestamp":1738650716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott\u2013Aldrich syndrome: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Le","family":"Nguyen Ngoc Quynh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binh","family":"Nguyen Thanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Luong Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Nguyen Thi Dieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong","family":"Dang Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"P. Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung","family":"Cao Viet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dien","family":"Tran Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002939","article-title":"Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report","volume":"135","author":"Burroughs","year":"2020","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2010.02.001","article-title":"Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment","volume":"30","author":"Pai","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2011.04.004","article-title":"Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation","volume":"24","author":"Locatelli","year":"2011","journal-title":"Best Pract Res Clin Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.52852\/tcncyh.v154i6.791","article-title":"First CD3\/CD45RA depleted haploidentical transplant for severe combined immunodeficiency disease with Rotavirus gastroenteritis in Vietnam","volume":"154","author":"Binh","year":"2022","journal-title":"T\u1ea1p ch\u00ed Nghi\u00ean c\u1ee9u Y h\u1ecdc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.0625","article-title":"Multi-institutional study of posttransplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning","volume":"32","author":"Kanakry","year":"2014","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.203","article-title":"Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases","volume":"42","author":"Brodsky","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.03.009","article-title":"Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children","volume":"25","author":"Neven","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15831","article-title":"How I manage patients with Wiskott Aldrich syndrome","volume":"185","author":"Rivers","year":"2019","journal-title":"Br J Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014687","article-title":"Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis","volume":"139","author":"Albert","year":"2022","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.jaci.2018.06.042","article-title":"One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years","volume":"142","author":"Elfeky","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001841","article-title":"Successful haploidentical stem cell transplant with posttransplant cyclophosphamide in Wiskott-Aldrich syndrome with myeloablative conditioning","volume":"43","author":"Sharma","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27092","article-title":"Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome","volume":"65","author":"Yue","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.647505","article-title":"Case report: haploidentical bone marrow transplantation in two brothers with Wiskott-Aldrich syndrome using their father as the donor","volume":"9","author":"Smith","year":"2021","journal-title":"Front Pediatr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.52852\/tcncyh.v131i7.1567","article-title":"Gh\u00e9p t\u1ebf b\u00e0o g\u1ed1c n\u1eeda thu\u1eadn h\u1ee3p \u1edf tr\u1ebb suy gi\u1ea3m mi\u1ec5n d\u1ecbch ti\u00ean ph\u00e1t th\u1ec3 ph\u1ed1i h\u1ee3p tr\u1ea7m tr\u1ecdng","volume":"131","author":"Nguy\u1ec5n","year":"2020","journal-title":"T\u1ea1p Ch\u00ed Nghi\u00ean c\u1ee9u Y h\u1ecdc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00445","article-title":"Hematopoietic stem cell transplantation for primary immunodeficiencies","volume":"7","author":"Gennery","year":"2019","journal-title":"Front Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1002\/ctm2.815","article-title":"Gene therapy for Whiskott-Aldrich syndrome: The latest news","volume":"12","author":"Cavazzana","year":"2022","journal-title":"Clin Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1495666\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T06:31:58Z","timestamp":1738650718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1495666\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2025.1495666"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1495666","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"article-number":"1495666"}}